Cyclerion Therapeutics Inc • CYCN

Capital at risk.

About Cyclerion Therapeutics Inc
Ticker
info
CYCN
Trading on
info
NASDAQ
ISIN
info
US23255M1053
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Regina M. Graul Ph.D.
Headquarters
info
245 First Street, Riverview II, Cambridge, MA, United States, 02142
Employees
info
1
Website
info
cyclerion.com
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$8M
P/E ratio
info
-
EPS
info
-$0.69
Dividend Yield
info
0.00%
Beta
info
1.68
Forward P/E ratio
info
0
EBIDTA
info
$-9.6M
Ex dividend date
info
-
Price & volume
Market cap
info
$8M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
3.67
Price to book
info
0.93
Earnings
EPS
info
-$0.69
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-9.6M
Revenues (TTM)
info
$2.2M
Revenues per share (TTM)
info
$0.81
Technicals
Beta
info
1.68
52-week High
info
$9.47
52-week Low
info
$1.27
50-day moving average
info
$2.88
200-day moving average
info
$2.93
Short ratio
info
0.23
Short %
info
0.45%
Management effectiveness
ROE (TTM)
info
-22.43%
ROA (TTM)
info
-24.15%
Profit margin
info
-89.51%
Gross profit margin
info
$2.2M
Operating margin
info
-1,797.85%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
14.10%
Share stats
Outstanding Shares
info
3.2M
Float
info
2.5M
Insiders %
info
31.48%
Institutions %
info
11.44%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$4.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.29
-
-
Q3 • 24Beat
$0.21
-
-
Q4 • 24Beat
-$0.56
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.1M
$-1.4M
-1,764.20%
Q1 • 25
$0.1M
$-0.3M
-348.39%
Q2 • 25
14.81%
-77.33%
-80.25%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$9.8M
$1.1M
10.84%
Q1 • 25
$9.4M
$0.8M
8.54%
Q2 • 25
-4.84%
-25.02%
-21.21%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1M
-
$1.4M
$-1M
Q1 • 25
$-0.5M
-
$-0.1M
$-0.5M
Q2 • 25
-48.04%
-
-109.45%
-48.04%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cyclerion Therapeutics Inc share?
Collapse

Cyclerion Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Cyclerion Therapeutics Inc have?
Collapse

Cyclerion Therapeutics Inc currently has 3.2M shares.

Does Cyclerion Therapeutics Inc pay dividends?
Collapse

No, Cyclerion Therapeutics Inc doesn't pay dividends.

What is Cyclerion Therapeutics Inc 52 week high?
Collapse

Cyclerion Therapeutics Inc 52 week high is $9.47.

What is Cyclerion Therapeutics Inc 52 week low?
Collapse

Cyclerion Therapeutics Inc 52 week low is $1.27.

What is the 200-day moving average of Cyclerion Therapeutics Inc?
Collapse

Cyclerion Therapeutics Inc 200-day moving average is $2.93.

Who is Cyclerion Therapeutics Inc CEO?
Collapse

The CEO of Cyclerion Therapeutics Inc is Dr. Regina M. Graul Ph.D..

How many employees Cyclerion Therapeutics Inc has?
Collapse

Cyclerion Therapeutics Inc has 1 employees.

What is the market cap of Cyclerion Therapeutics Inc?
Collapse

The market cap of Cyclerion Therapeutics Inc is $8M.

What is the P/E of Cyclerion Therapeutics Inc?
Collapse

The current P/E of Cyclerion Therapeutics Inc is null.

What is the EPS of Cyclerion Therapeutics Inc?
Collapse

The EPS of Cyclerion Therapeutics Inc is -$0.69.

What is the PEG Ratio of Cyclerion Therapeutics Inc?
Collapse

The PEG Ratio of Cyclerion Therapeutics Inc is null.

What do analysts say about Cyclerion Therapeutics Inc?
Collapse

According to the analysts Cyclerion Therapeutics Inc is considered a buy.